Showing results (191-200 of 403) with videos related to

Sort By:
Pageof 41
Clinical Immunology (Orlando, Fla.)|April 5, 2001
Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMCM Linker-Israeli, E Elstner, J R Klinenberg, et al.
Leukemia Research|May 10, 2006
Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndromeW-K Hofmann, S Takeuchi, N Takeuchi, et al.
Anticancer Research|September 1, 1994
Mutant p53 proteins behave in a dominant, negative fashion in vivoM Hachiya, A Chumakov, C W Miller, et al.
Leukemia|October 27, 1997
Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4AA F Gombart, R Yang, M J Campbell, et al.
British Journal of Cancer|January 26, 2000
Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivoK Koshiuka, E Elstner, E Williamson, et al.
Blood|August 15, 1995
Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomasA F Gombart, R Morosetti, C W Miller, et al.
British Journal of Haematology|June 3, 1998
Microsatellite instability in adult T-cell leukaemiaY Hatta, Y Yamada, M Tomonaga, et al.
Oncogene|July 19, 2011
Dominant-negative mechanism of leukemogenic PAX5 fusionsN Kawamata, M A Pennella, J L Woo, et al.
Cancer Research|September 1, 1993
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplificationJ Imamura, C R Bartram, F Berthold, et al.
Biochemical and Biophysical Research Communications|March 17, 1995
Transgenic mice overexpressing human copper/zinc-superoxide dismutase (Cu/Zn SOD) are not resistant to endotoxic shockS de Vos, C J Epstein, E Carlson, et al.
Pageof 41